Mediq Danmark A/S
A/SActiveCVR 86479915Dirch Passers Allé 76, 2000 FrederiksbergWholesale of pharmaceutical and medical goods· NACE 4646Est. 1979 · 47 years old120 employees
Loading company…
Overview
Mediq Danmark A/S is a Danish A/S based in Frederiksberg, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 1979, the company has 120 employees and reported revenue of DKK 634.6m in its latest annual filing.
Revenue 2025
634.6M DKK
−14% vs 2024
EBITDA margin
2.9 %
−55% vs 2024
Net profit 2025
3M DKK
-89% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
49.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
1.3×
AverageAround the average of companies in the same industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
1.1 %
AverageAround the average of companies in the same industry
20212025
EBITDA — year on year
DKK millionsKey figures
Annual report 2025| Revenue | 634.6M DKK | -14% |
| EBITDA | 18.5M DKK | -55% |
| Net profit | 3M DKK | -89% |
| Total assets | 262.8M DKK | -24% |
| Equity | 130.6M DKK | -21% |
| Employees | 120 | — |
Company information
Legal name
MEDIQ DANMARK A/S
CVR number
86479915
Legal form
Aktieselskab
NACE code
Founded
30 April 1979 · 47 years
Share capital
DKK 5,010,000
Employees
120 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med formanden for bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er salg, distribution og markedsføring af forbrugsvarer og udstyr til sundhedssektoren i Norden samt virksomhed, der efter bestyrelsens skøn står i naturlig forbindelse hermed.
(no translation available)
Contact
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Mediq Danmark A/S reported revenue of DKK 634.6m, a decrease of 14% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 3.0m, and the EBITDA margin stood at 2.9%.
At the end of 2025, equity financed 49.7% of the balance sheet, and current assets covered short-term debt 1.3 times.
Financials
Revenue
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 634,585 | 736,421 | 786,760 | 727,630 | 786,101 |
| Staff expenses | -98,815 | -121,505 | -112,373 | -111,643 | -104,621 |
| EBITDA | 18,491 | 41,424 | 66,149 | 59,464 | 79,190 |
| Depreciation & amort. | -16,466 | -9,698 | -8,981 | -7,996 | -6,326 |
| EBIT | 2,025 | 31,726 | 57,168 | 51,468 | 72,864 |
| Net financials | -456 | 4,251 | 6,530 | 2,534 | 3,902 |
| Profit before tax | 1,569 | 35,977 | 63,698 | 54,002 | 76,766 |
| Tax | -1,409 | 9,955 | 12,529 | 14,359 | 17,400 |
| Net profit | 2,978 | 26,022 | 51,169 | 39,643 | 59,366 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 262,754 | 346,441 | 429,290 | 378,322 | 357,086 |
| Equity | 130,611 | 165,633 | 179,611 | 178,442 | 180,799 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 131,918 | 178,088 | 249,679 | 199,880 | 176,287 |
| Total debt | 131,918 | 178,088 | 249,679 | 199,880 | 176,287 |
Financial ratios
5-year trendEBITDA margin
2.9 %
20212025
Equity ratio
49.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Return on equity
2.3 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Net profit margin
0.5 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Asset turnover
2.42×
StrongAmong the 30% highest rated companies in the industry
20212025
Debt / equity
1.01×
AverageAround the average of companies in the same industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginAverage
Around the average of companies in the same industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginWeak
Among the 40% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginWeak
Among the 40% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 40% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 40% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioAverage
Around the average of companies in the same industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioStrong
Among the 40% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 10% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalWeak
Among the 30% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery strong
Among the 10% highest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 40% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 40% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityAverage
Around the average of companies in the same industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityAverage
Around the average of companies in the same industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageWeak
Among the 40% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtAverage
Around the average of companies in the same industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginAverage
Around the average of companies in the same industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverStrong
Among the 30% highest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverVery weak
Among the 20% lowest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalStrong
Among the 30% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 20% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 20% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PK Chief Executive Officer | Chief Executive Officer | 2026 |
Former (13)
CB Chief Executive Officer | Chief Executive Officer | 2011 – 2011 |
JH Management | Management | 2006 – 2013 |
PM Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
JM Management | Management | 2012 – 2015 |
TH Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
BM Deputy | Deputy | 1979 – 2002 |
KB Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
JB Chief Executive Officer | Chief Executive Officer | 2006 – 2011 |
UJ Management | Management | 2015 – 2019 |
JA Management | Management | 2015 – 2015 |
HK Management | Management | 1979 – 2006 |
TA Deputy | Deputy | 1979 – 2006 |
CK Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
RP Board of Directors | Board of Directors | 2023 |
JW Chairman | Chairman | 2025 |
RD Board of Directors | Board of Directors | 2026 |
Former (25)
JH Chairman | Chairman | 2019 – 2020 |
AG Chairman | Chairman | 2006 – 2007 |
PM Chairman | Chairman | 2023 – 2024 |
ES Board of Directors | Board of Directors | 1979 – 1991 |
FE Chairman | Chairman | 2007 – 2008 |
TH Chairman | Chairman | 2024 – 2025 |
LM Board of Directors | Board of Directors | 1979 – 2006 |
SF Board of Directors | Board of Directors | 1979 – 2006 |
ML | Chairman | 2008 – 2009 |
KB Board of Directors | Board of Directors | 2020 – 2024 |
JB Chairman | Chairman | 2011 – 2015 |
GL Board of Directors | Board of Directors | 1979 – 2006 |
MC Board of Directors | Board of Directors | 2007 – 2014 |
UJ Board of Directors | Board of Directors | 2019 – 2019 |
OM Board of Directors | Board of Directors | 2006 – 2007 |
JA Chairman | Chairman | 2015 – 2019 |
BF Chairman | Chairman | 1979 – 2006 |
HK Board of Directors | Board of Directors | 1979 – 2007 |
LH Board of Directors | Board of Directors | 2019 – 2020 |
PG Board of Directors | Board of Directors | 2006 – 2007 |
EK Board of Directors | Board of Directors | 1979 – 2006 |
JG Chairman | Chairman | 2015 – 2015 |
PR Board of Directors | Board of Directors | 2018 – 2019 |
CK Chairman | Chairman | 2020 – 2023 |
FJ Board of Directors | Board of Directors | 2014 – 2015 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
MEDIQ HOLDING DANMARK ApS
Mediq Danmark A/S Board network connections
Board members of Mediq Danmark A/S also hold positions in 61 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ejvind Sandal | Board of Directors | 12 companiesMany roles |
| Katrine Bjarkov Benthien | Chief Executive Officer | 9 companiesMany roles |
| Philip Mørch Nadelmann | Chief Executive Officer | 5 companies |
| Jan Mark Kolbye Jensen | Management | 5 companies |
| Jesper Boysen | Chief Executive Officer | 5 companies |
| Ole Mikael Jensen | Board of Directors | 5 companies |
| Christian Kanstrup | Chief Executive Officer | 4 companies |
| Ulrik Juul Rokkedal Therkildsen | Management | 3 companies |
| Jørgen Appel Kelkjær | Management | 3 companies |
| Claus Bildsøe Astrup | Chief Executive Officer | 2 companies |
| Erik Korpela-Andersen | Board of Directors | 2 companies |
| Jan Henning Albrechtsen | Management | 1 company |
| Peter Kluge Andersen | Chief Executive Officer | 1 company |
| Hans Kristian Fischlein | Management | 1 company |
| Robert Paul Janse | Board of Directors | 1 company |
| Susanne Fischlein Hansen | Board of Directors | 1 company |
| Birgit Fischlein | Chairman | 1 company |
Frequently asked questions
What is the CVR number of Mediq Danmark A/S?
Mediq Danmark A/S is registered with CVR / Virk under CVR 86479915.
What is the revenue of Mediq Danmark A/S?
Mediq Danmark A/S reported revenue of DKK 634.6m in 2025.
How many employees does Mediq Danmark A/S have?
Mediq Danmark A/S employs 120 people as of the latest annual report.
Who is the CEO of Mediq Danmark A/S?
Peter Kluge Andersen is the CEO of Mediq Danmark A/S, in role since 2026.
Who is the chairman of Mediq Danmark A/S?
Joachim Warnberg chairs the board of Mediq Danmark A/S, in role since 2025.
Where is Mediq Danmark A/S headquartered?
Mediq Danmark A/S's registered address is Dirch Passers Allé 76.